These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4594678)

  • 41. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of the antibacterial action of dimethyl sulfoxide].
    Fomin DKh; Tatchin SM; Veselovskaia LI; Alycheva IS
    Antibiotiki; 1974 Aug; 19(8):745-8. PubMed ID: 4616643
    [No Abstract]   [Full Text] [Related]  

  • 43. Observations on the mode of action of cefoxitin.
    Onishi HR; Zimmerman SB; Stapley EO
    Ann N Y Acad Sci; 1974 May; 235(0):406-25. PubMed ID: 4604846
    [No Abstract]   [Full Text] [Related]  

  • 44. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical and microbiological studies on a new broad-spectrum antibiotic gentamycin].
    Weitgasser H
    Hautarzt; 1967 Aug; 18(8):370-3. PubMed ID: 4872260
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of the variations in inoculum on the cephalosporins' in vitro antibacterial activity.
    Cafarelli A; Magliulo E; Piantieri G
    G Batteriol Virol Immunol; 1981; 74(1-6):26-38. PubMed ID: 6458525
    [No Abstract]   [Full Text] [Related]  

  • 47. [Frequency and antibiotic susceptibility of bacteria identified in urine].
    Sekhsokh Y; Chadli M; El Hamzaoui SA
    Med Mal Infect; 2008 Jun; 38(6):324-7. PubMed ID: 18395378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antibiotic and inhibiting effect of proteus].
    Kerasheva SI; Rakhtanova EP; Zvereva NM
    Antibiotiki; 1973 Mar; 18(3):236-9. PubMed ID: 4587462
    [No Abstract]   [Full Text] [Related]  

  • 50. The antibacterial and pharmacological activity of oxolinic acid (Prodoxol).
    Kershaw MJ; Leigh DA
    J Antimicrob Chemother; 1975 Sep; 1(3):311-5. PubMed ID: 810473
    [No Abstract]   [Full Text] [Related]  

  • 51. [Change of resistance and resistance status of the important pathogenic bacteria species (with consideration to carbenicillin)].
    Legler F
    Med Klin; 1970 May; 65(21):1037-9. PubMed ID: 4941397
    [No Abstract]   [Full Text] [Related]  

  • 52. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

  • 53. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents.
    Rohrich PJ; Ling GV; Ruby AL; Jang SS; Johnson DL
    J Am Vet Med Assoc; 1983 Oct; 183(8):863-7. PubMed ID: 6415021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Intestinal microflora in mice and its change under the effect of antibiotics].
    Kiselev RN
    Antibiotiki; 1968 Aug; 13(8):708-12. PubMed ID: 4879870
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies on the cross resistance of bacteria to sulfonamides. 3. The behavior of bacteria toward sulfonamides substituted in N1 with an acyl, carbamyl, thiocarbamyl or guanidyl group].
    Patsch R; Höhne C
    Zentralbl Bakteriol Orig; 1967 Jan; 202(2):227-32. PubMed ID: 4970772
    [No Abstract]   [Full Text] [Related]  

  • 56. [In vitro antibacterial activity of tetracycline, oleandomycin and their combination on 836 bacterial strains].
    Liani M; Renzini G; Dominici A
    Antibiotica; 1969 Sep; 7(3):219-33. PubMed ID: 4948395
    [No Abstract]   [Full Text] [Related]  

  • 57. [Rapid method for the determination of sensitivity of bacterial cultures to various antibiotics in liquid medium].
    Levi MI; Gorozhankina IA; Sagatovskaia LA
    Antibiotiki; 1967 Jan; 12(1):57-60. PubMed ID: 4872773
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of 4-(2,4-dichlorophenoxy) butyric acid on Bacillus and other gram-positive and gram-negative bacteria cultures].
    Román M; González C; Rodríguez D
    Zentralbl Bakteriol Parasitenkd Infektionskr Hyg; 1970; 124(2):119-28. PubMed ID: 4918691
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antimicrobial activity of cephapirin (author's transl)].
    Miyamura S; Ochiai H
    Jpn J Antibiot; 1974 Apr; 27(2):148-51. PubMed ID: 4603343
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of a new cephalosporin antibiotic, cephapirin.
    Wiesner P; MacGregor R; Bear D; Berman S; Holmes K; Turck M
    Antimicrob Agents Chemother; 1972 Apr; 1(4):303-9. PubMed ID: 4208896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.